Open Markets Institute supports US antitrust case against Amgen over Enbrel
MLex Summary: The Open Markets Institute told a US appeals court that the Sherman Act applies to acquisitions of all kinds of assets, including patents and patent applications. OMI filed a...To view the full article, register now.
Already a subscriber? Click here to view full article